Screening for early indicators of cervical disease is a major component of women’s health programs throughout the world.1

Despite efforts to screen for cervical disease, cervical cancer remains one of the most common and fatal types of cancer affecting women.1

Better understanding of the epidemiology and biology of cervical cancer can help healthcare professionals and laboratories implement clinically validated screening measures that avoid over management of women while identifying those truly at risk.1